Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 1
- DOI:
- No doi available
- Key Word:
- hypertension,pulmonary;heart defects,congenital;rho-associated kinase;fasudil
Abstract： Background The RhoA/Rho kinase pathway may participate in the pathogenesis of hypoxia and monocrotaline induced pulmonary hypertension. This study tested whether RhoA/Rho kinase pathway is involved in the pathogenesis of high flow induced pulmonary hypertension in rats.Methods Male Wistar rats (4 weeks) were randomly divided into 4 shunt groups, 4 treated groups and 4 control groups.Shunt and treated groups underwent left common carotid artery/external jugular vein shunt operation. Control groups underwent sham operation. Treated groups received fasudil treatment and the others received same dose of saline. At weeks 1, 2, 4 and 8 of the study, right ventricular systolic pressure was measured and blood gases were analysed to calculate Qp/Qs. The weight ratio of right ventricle to left ventricle plus septum and the mean percentage of medial wall thickness in moderate sized pulmonary arteries were obtained. RhoA activity in pulmonary arteries was detected using Rho activity assay reagent. Rho kinase activity was quantified by the extent of MYPT1 phosphorylation with Western blot.Proliferating cells were evaluated using proliferating cell nuclear antigen immunohistological staining.Results Carotid artery/jugular vein shunt resulted in high pulmonary blood flow, both an acute and a chronic elevation of right ventricular systolic pressure, significant medial wall thickening characterized by smooth muscle cells proliferation,right ventricular hypertrophy and increased activation of RhoA and Rho kinase. Fasudil treatment lowered pulmonary artery systolic pressure, suppressed pulmonary artery smooth muscle cells proliferation, attenuated pulmonary artery medial wall thickening and inhibited right ventricular hypertrophy together with significant suppression of Rho kinase activity but not Rho activity.Conclusions Activated RhoA/Rho kinase pathway is associated with both the acute pulmonary vasoconstriction and the chronic pulmonary artery remodelling of high flow induced pulmonary hypertension. Fasudil treatment could improve pulmonary hypertension by inhibiting Rho kinase activity.
- [1]李晓惠,杜军保,汤秀英,等.大鼠高肺血流性肺动脉高压形成中肺血管结构的变化[J].2005,(4).
- [2]H, Shimokawa,M, Seto,N, Katsumata,etc.Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm.[J].1999,43.
- [3]Asad, Zeidan,Ina, Nordstr?m,Sebastian, Albinsson,etc.Stretch-induced contractile differentiation of vascular smooth muscle: sensitivity to actin polymerization inhibitors.[J].2003,284(6).
- [4]M, Uehata,T, Ishizaki,H, Satoh,etc.Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension.[J].1997,389(6654).
- [5]Somlyo AV,Somlyo AP.Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.[J].2003,83(4).
- [6]Civelek Mete,Ainslie Kristy,Garanich Jeff S.,etc.Smooth muscle cells contract in response to fluid flow via a Ca2+-independent signaling mechanism[J].2002.
- [7]Sheng, Li,Hideyuki, Tanaka,Hong Hui, Wang,etc.Intracellular signal transduction for migration and actin remodeling in vascular smooth muscle cells after sphingosylphosphorylcholine stimulation.[J].2006,291(3).
- [8]Katsumi A,del Pozo MA,Chien S,etc.Effects of cell tension on the small GTPase Rac.[J].2002,158(1).
- [9]Nakamura M,Ishikura K,Yamada N,etc.Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension.[J].2006,70(2).
- [10]K, Numaguchi,S, Eguchi,T, Yamakawa,etc.Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments.[J].1999,85.
- [11]Hellstrand P,Albinsson S.Stretch-dependent growth and differentiation in vascular smooth muscle: role of the actin cytoskeleton.[J].2005,83(10).
- [12]Bleich M,Lohn M,Busch AE,etc.Inhibition of Rho-kinase stimulates nitric oxide-independent vasorelaxation.[J].2005,507(1).
- [13]Cheng BL,Datta R,Taylor JE,etc.Human urotensin II-induced aorta ring contractions are mediated by protein kinase C, tyrosine kinases and Rho-kinase: inhibition by somatostatin receptor antagonists.[J].2002,438(3).
- [14]Andrew J, Putnam,James J, Cunningham,Brendan B L, Pillemer,etc.External mechanical strain regulates membrane targeting of Rho GTPases by controlling microtubule assembly.[J].2003,284(3).
- [15]Kaibuchi K,Ruffieux J,Viswambharan H,etc.Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells[J].2002,22(24).
- [16]Tetsutaro, Nagaoka,Yoshiteru, Morio,Nina, Casanova,etc.Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats.[J].2004,287(4).
- [17]A, Hall.Rho GTPases and the actin cytoskeleton.[J].1998,279.
- [18]Hilgers RH,Webb RC.Molecular aspects of arterial smooth muscle contraction: focus on Rho.[J].2005,230(11).
- [19]Chaoshu T,Junbao D,Hui Y,etc.Effect of L-arginine on collagen of high flow-induced pulmonary arterial remodeling.[J].2005,69(5).
- [20]Le Jeune-H,Loirand G,Lohmann SM,etc.Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.[J].2000,275(28).
- [21]Fanburg BL,Liu Y.Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1.[J].2006,34(2).
- [22]Ellerbroek SM,Wennerberg K,Burridge K.Serine phosphorylation negatively regulates RhoA in vivo.[J].2003,278(21).
- [23]Tokui T.,Kaibuchi K.,Yano T.,etc.Cytoskeletal Rearrangements and Transcriptional Activation of C-Fos Serum Response Element by Rho-Kinase[J].1997,272(40).